About Us

David Brachman

David G. Brachman, MD, FASTRO

Co-Founder and Chief Technology Officer

Dr Brachman was instrumental in the development of GammaTile Therapy. He is a cofounder and the chief technology officer of GT Medical Technologies, as well as an inventor on all of the company’s product patents. A nationally recognized radiation oncologist and researcher and the author of more than 50 peer-reviewed publications. His publishing credits include The LancetCancer Research, and The New England Journal of Medicine. Dr Brachman is renowned for his extensive neuro-oncology clinical expertise.

Dr Brachman recently retired from practice after more than 15 years as the chairman and medical director of the Radiation Oncology department and codirector of the GammaKnife program at St. Joseph’s Hospital and Medical Center and Barrow Neurological Institute in Phoenix, Arizona. His considerable radiation oncology background includes a position as the professor of Radiation Oncology at the University of Arizona College of Medicine – Phoenix, and more than 15 years as a member of the NCI-sponsored Radiation Therapy Oncology Group CNS Tumor Steering Committee.